FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4320170152> ?p ?o ?g. }

• W4320170152 abstract "Fluvoxamine (FLV) is a well-tolerated, widely accessible antidepressant of the selective serotonin reuptake inhibitor (SSRI) category. It was formerly used to reduce anxiety, obsessive-compulsive disorder, panic attacks, and depression. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an enclosed ribonucleic acid (RNA) virus with a positive-sense RNA genome that belongs to the Coronaviridae family. Infection with SARS-CoV-2 causes clinical deterioration, increased hospitalization, morbidity, and death. As a result, the purpose of this research was to review FLV and its use in the treatment of SARS-CoV-2. FLV is a potent sigma-1 receptor (S1R) agonist that modulates inflammation by reducing mast cell downregulation, cytokine production, platelet aggregation, interfering with endolysosomal viral transport, and delaying clinical deterioration. FLV treatment reduced the requirement for hospitalization in high-risk outpatients with early identified coronavirus disease 2019 (COVID-19), defined by detention in a COVID-19 emergency department or transfer to a tertiary hospital. In addition, FLV may reduce mortality and risk of hospital admission or death in patients with SARS-CoV-2. The most common adverse effect is nausea; other gastrointestinal symptoms, neurologic consequences, and suicidal thoughts may also occur. There is no evidence that FLV can treat children with SARS-CoV-2. Although FLV is not expected to increase the frequency of congenital abnormalities during pregnancy, this risk must be balanced with the potential benefit. More research is required to determine the effectiveness, dose, and mechanisms of action of FLV; however, FLV appears to offer significant promise as a safe and widely accessible drug that can be repurposed to reduce substantial morbidity and mortality due to SARS-CoV-2." @default.
• W4320170152 created "2023-02-13" @default.
• W4320170152 creator A5003331008 @default.
• W4320170152 creator A5008587922 @default.
• W4320170152 creator A5016262664 @default.
• W4320170152 creator A5018147747 @default.
• W4320170152 creator A5037294281 @default.
• W4320170152 creator A5043588332 @default.
• W4320170152 creator A5048640745 @default.
• W4320170152 creator A5069131392 @default.
• W4320170152 creator A5073498693 @default.
• W4320170152 creator A5081531208 @default.
• W4320170152 date "2023-01-24" @default.
• W4320170152 modified "2023-10-14" @default.
• W4320170152 title "An Overview of Fluvoxamine and its Use in SARS-CoV-2 Treatment" @default.
• W4320170152 cites W1501635529 @default.
• W4320170152 cites W1849790101 @default.
• W4320170152 cites W1892860189 @default.
• W4320170152 cites W1931711671 @default.
• W4320170152 cites W1944747211 @default.
• W4320170152 cites W1970705129 @default.
• W4320170152 cites W1970897378 @default.
• W4320170152 cites W1971595958 @default.
• W4320170152 cites W1978938302 @default.
• W4320170152 cites W1984946899 @default.
• W4320170152 cites W1992568187 @default.
• W4320170152 cites W1997361683 @default.
• W4320170152 cites W2000434613 @default.
• W4320170152 cites W2002439304 @default.
• W4320170152 cites W2006066616 @default.
• W4320170152 cites W2009882421 @default.
• W4320170152 cites W2018603575 @default.
• W4320170152 cites W2019079031 @default.
• W4320170152 cites W2020183127 @default.
• W4320170152 cites W2021993761 @default.
• W4320170152 cites W2022039090 @default.
• W4320170152 cites W2026644386 @default.
• W4320170152 cites W2028370526 @default.
• W4320170152 cites W2040462912 @default.
• W4320170152 cites W2051062943 @default.
• W4320170152 cites W2055005801 @default.
• W4320170152 cites W2055527252 @default.
• W4320170152 cites W2080293954 @default.
• W4320170152 cites W2085670677 @default.
• W4320170152 cites W2091828873 @default.
• W4320170152 cites W2131952231 @default.
• W4320170152 cites W2169264276 @default.
• W4320170152 cites W2313035924 @default.
• W4320170152 cites W2460946499 @default.
• W4320170152 cites W2483764570 @default.
• W4320170152 cites W2730432911 @default.
• W4320170152 cites W2769072089 @default.
• W4320170152 cites W2914443670 @default.
• W4320170152 cites W2968772731 @default.
• W4320170152 cites W3001456238 @default.
• W4320170152 cites W3002108456 @default.
• W4320170152 cites W3009912996 @default.
• W4320170152 cites W3012721715 @default.
• W4320170152 cites W3021939159 @default.
• W4320170152 cites W3022285953 @default.
• W4320170152 cites W3036681929 @default.
• W4320170152 cites W3042442225 @default.
• W4320170152 cites W3088505298 @default.
• W4320170152 cites W3095260125 @default.
• W4320170152 cites W3101087608 @default.
• W4320170152 cites W3102920585 @default.
• W4320170152 cites W312134578 @default.
• W4320170152 cites W3128592226 @default.
• W4320170152 cites W3133935677 @default.
• W4320170152 cites W3152668228 @default.
• W4320170152 cites W3164746373 @default.
• W4320170152 cites W3185641161 @default.
• W4320170152 cites W3197191145 @default.
• W4320170152 cites W3201551509 @default.
• W4320170152 cites W3208093760 @default.
• W4320170152 cites W3208556307 @default.
• W4320170152 cites W4210457246 @default.
• W4320170152 cites W4226119629 @default.
• W4320170152 cites W4235804341 @default.
• W4320170152 cites W4247331516 @default.
• W4320170152 cites W4308524269 @default.
• W4320170152 doi "https://doi.org/10.7759/cureus.34158" @default.
• W4320170152 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36843775" @default.
• W4320170152 hasPublicationYear "2023" @default.
• W4320170152 type Work @default.
• W4320170152 citedByCount "0" @default.
• W4320170152 crossrefType "journal-article" @default.
• W4320170152 hasAuthorship W4320170152A5003331008 @default.
• W4320170152 hasAuthorship W4320170152A5008587922 @default.
• W4320170152 hasAuthorship W4320170152A5016262664 @default.
• W4320170152 hasAuthorship W4320170152A5018147747 @default.
• W4320170152 hasAuthorship W4320170152A5037294281 @default.
• W4320170152 hasAuthorship W4320170152A5043588332 @default.
• W4320170152 hasAuthorship W4320170152A5048640745 @default.
• W4320170152 hasAuthorship W4320170152A5069131392 @default.
• W4320170152 hasAuthorship W4320170152A5073498693 @default.
• W4320170152 hasAuthorship W4320170152A5081531208 @default.
• W4320170152 hasBestOaLocation W43201701521 @default.
• W4320170152 hasConcept C118552586 @default.
• W4320170152 hasConcept C126322002 @default.

• next